Antiparasitic Drugs Market Size

Antiparasitic Drugs Market Size

Antiparasitic Drugs Market was valued at USD 22.7 billion in 2023 and is estimated to grow at a CAGR of 5.7% between 2024 and 2032 to reach USD 37 billion by 2032. High market growth can be attributed to factors such as rising prevalence of parasitic infections, increasing global travel and migration, and increasing public awareness campaigns and educational programs.

To get key market trends

  Download Free Sample

For instance, according to the World Health Organization, in 2023, over 600 million people were estimated to be infected by Strongyloides stercoralis (helminths), with highest prevalence reported in sub-Saharan Africa, China, South America, and Asia. Such high prevalence of parasitic infections globally contributes to a growing disease burden. This rise in the number of infected individuals creates a greater demand for effective treatment options, thereby driving the antiparasitic drugs market.
 

Antiparasitic drugs are a class of medications specifically designed to treat infections caused by parasitic organisms. Parasites are living organisms that depend on other organisms, known as hosts, for their survival and reproduction. Parasites can include various types of organisms, such as protozoa, helminths (worms), and arthropods. Antiparasitic drugs act by different mechanisms, such as killing the parasite, inhibiting its growth and reproduction, or interfering with its ability to infect the host.